| 2937 | | Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: | | | | |
| 2940..00 | | Sugars, chemically pure, other than sucrose, lactose, maltose, glucose and fructose; sugar ethers, sugar acetals and sugar esters, and their salts, other than products of heading 2937, 2938 or 2939: | | | | |
| 2940.00.20 | 00 | D-Arabinose | kg | Free | | 50% |
| 2941.10.30 | 00 | Carfecillin, sodium; Cloxacillin, sodium; Dicloxacillin, sodium; Flucloxacillin (Floxacillin); and Oxacillin, sodium | kg | Free | | 15.4￠/kg + 45% |
| 2941.90.30 | 00 | Aromatic or modified aromatic | kg | Free | | 15.4￠/kg + 45% |
| 2942.00.03 | 00 | Aromatic or modified aromatic: | | | | |
| 3001 | | Glands and other organs for organotherapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organotherapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included: | | | | |
| 3002 | | Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: | | | | |
| 3002.30.00 | 00 | Vaccines for veterinary medicine | kg | Free | | Free |
| 3002.90.51 | 20 | Antiallergenic preparations | kg | | | |
| 3003.39.10 | 00 | Artificial mixtures of natural hormones | g | Free | | 25% |
| 3004.10.10 | 10 | For veterinary use | kg | | | |
| 3004.10.50 | 10 | For veterinary use | kg | | | |
| 3004.20.00 | 10 | For veterinary use | kg | | | |
| 3004.39.00 | 10 | For veterinary use | kg | | | |
| 3004.40.00 | 05 | For veterinary use | kg | | | |
| 3004.40.00 | 10 | Cardiovascular medicaments | kg | | | |
| 3004.40.00 | 20 | Medicaments primarily affecting the central nervous system: | | | | |
| 3004.40.00 | 60 | Medicaments primarily affecting the eyes, ears or respiratory system | kg | | | |
| 3004.50.10 | 00 | Containing vitamins synthesized wholly or in part from aromatic or modified aromatic industrial organic compounds: | | | | |
| 3004.50.50 | 05 | For veterinary use | kg | | | |
| 3004.90.91 | 03 | For veterinary use | kg | | | |
| 3004.90.91 | 65 | Preparations primarily affecting the electrolytic, caloric or water balance: | | | | |
| 3004.90.91 | 76 | Cough and cold preparations | kg | | | |
| 3004.90.91 | 20 | Cardiovascular medicaments | kg | | | |
